Visanne, also known by the generic name dienogest, will have its cost reduced from more than $800 per year for a course of ...

The following is a summary of “Surgery versus non-surgical treatment for endometriosis-related pain during the COVID-19 ...

The drug Visanne (also known as dienogest) is the first endometriosis treatment to be added to the Pharmaceutical Benefits ...

Visanne is officially the first endometriosis treatment medication to be subsidised by the government in 30 years, more than ...

For the 1 in 7 women affected by endometriosis, the news of a government subsidised treatment drug could be life-changing.

Discover 5 signs that your menstrual cramps may be more than normal pain and could indicate endometriosis as shared by an ...

People living with endometriosis will now have easier access to treatment after dienogest was added to the Pharmaceutical Benefits Scheme.

Endometriosis is a complex condition that affects millions of individuals worldwide Characterized by the growth of endometrial-like tissue outside the uterus this condition can lead to debilitating pa ...

The market for endometriosis treatment is projected to attain a value of US$ 3.1 billion by 2034. According to Transparency ...

The federal government today announced the move to subsidise endometriosis treatment, via the drug Visanne, greatly improving accessibility.

“Our Government’s listing of Visanne on the PBS will be a game changer for women living with endo. Making this medicine ...

Despite a cost-of-living crisis, young people aged 25 to 29 have had the biggest take-up of private health insurance over the ...